MwanzoI5X • FRA
add
Precigen Inc
Bei iliyotangulia
€ 3.44
Bei za siku
€ 3.37 - € 3.44
Bei za mwaka
€ 0.63 - € 4.30
Thamani ya kampuni katika soko
1.13B USD
Wastani wa hisa zilizouzwa
206.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | elfu 856.00 | 19.39% |
Matumizi ya uendeshaji wa biashara | 27.16M | 8.29% |
Mapato halisi | -26.64M | 54.68% |
Kiwango cha faida halisi | elfu -3.11 | 62.04% |
Mapato kwa kila hisa | -0.08 | 23.22% |
EBITDA | -27.23M | -10.23% |
Asilimia ya kodi ya mapato | -0.01% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 59.75M | 205.86% |
Jumla ya mali | 101.90M | 39.28% |
Jumla ya dhima | 107.79M | 259.43% |
Jumla ya hisa | -5.90M | — |
hisa zilizosalia | 297.97M | — |
Uwiano wa bei na thamani | -28.70 | — |
Faida inayotokana na mali | -60.38% | — |
Faida inayotokana mtaji | -691.86% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | -26.64M | 54.68% |
Pesa kutokana na shughuli | -18.98M | 17.87% |
Pesa kutokana na uwekezaji | 28.44M | 90.18% |
Pesa kutokana na ufadhili | -1.77M | -3,496.15% |
Mabadiliko halisi ya pesa taslimu | 7.70M | 194.68% |
Mtiririko huru wa pesa | -15.55M | 23.39% |
Kuhusu
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
21 Mei 1998
Tovuti
Wafanyakazi
143